KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+20.68%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$257M
AUM Growth
+$257M
(+15%)
Cap. Flow
-$333K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
99.62%
Holding
17
New
2
Increased
1
Reduced
2
Closed
2
Top Buys
1 |
Enlivex Therapeutics
ENLV
|
$2.46M |
2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$1.45M |
3 |
Cellectar Biosciences
CLRB
|
$33K |
Top Sells
1 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.46M |
2 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
$670K |
3 |
AKTX
Akari Therapeutics
AKTX
|
$78K |
4 |
ECTE
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
|
$62K |
Sector Composition
1 | Healthcare | 13.44% |